Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ana Grueso López"'
Autor:
Luis de la Cruz-Merino, Antonio Barco-Sánchez, Fernando Henao Carrasco, Esteban Nogales Fernández, Ana Vallejo Benítez, Javier Brugal Molina, Antonio Martínez Peinado, Ana Grueso López, Manuel Ruiz Borrego, Manuel Codes Manuel de Villena, Víctor Sánchez-Margalet, Adoración Nieto-García, Emilio Alba Conejo, Noelia Casares Lagar, José Ibáñez Martínez
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
Recently, immune edition has been recognized as a new hallmark of cancer. In this respect, some clinical trials in breast cancer have reported imppressive outcomes related to laboratory immune findings, especially in the neoadjuvant and metastatic se
Externí odkaz:
https://doaj.org/article/36ffc2f0d4ef48a583d787aa755ca221
Autor:
Luis de la Cruz-Merino, Marylène Lejeune, Esteban Nogales Fernández, Fernando Henao Carrasco, Ana Grueso López, Ana Illescas Vacas, Mariano Provencio Pulla, Cristina Callau, Tomás Álvaro
Publikováno v:
Clinical and Developmental Immunology, Vol 2012 (2012)
Hodgkin's lymphoma represents one of the most frequent lymphoproliferative syndromes, especially in young population. Although HL is considered one of the most curable tumors, a sizeable fraction of patients recur after successful upfront treatment o
Externí odkaz:
https://doaj.org/article/216210157c9749aa8cea472331f1ee99
Autor:
Pilar Tamayo Alonso, David Pérez-Callejo, Dolores Caballero Barrigón, Ignacio García Escobar, Ana Grueso López, Judit Rubio, Mariano Provencio Pulla, Elena Almagro Casado
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
This study was conducted to investigate the prognostic effect and implications of gallium 67 scintigraphy (gallium scan) at mid-treatment and at the end of first-line treatment in patients with early- and advanced-stage Hodgkin's lymphoma (HL). A tot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2bb79e1bad3eba1da264167adc33df8
https://doi.org/10.3892/mco.2015.670
https://doi.org/10.3892/mco.2015.670
Autor:
Adoracion Nieto-Garcia, Manuel Codes Manuel de Villena, Luis de la Cruz-Merino, Ana Grueso López, Víctor Sánchez-Margalet, Antonio Barco-Sánchez, Ana Vallejo Benítez, Antonio Martínez Peinado, Emilio Alba Conejo, Esteban Nogales Fernández, José Ibáñez Martínez, Noelia Casares Lagar, Javier Brugal Molina, Fernando Henao Carrasco, Manuel Ruiz Borrego
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
Clinical and Developmental Immunology
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Clinical and Developmental Immunology
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Recently, immune edition has been recognized as a new hallmark of cancer. In this respect, some clinical trials in breast cancer have reported imppressive outcomes related to laboratory immune findings, especially in the neoadjuvant and metastatic se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29c5c1e48f76cf7cd5da68c6f34230ba
https://idus.us.es/xmlui/handle/11441/18259
https://idus.us.es/xmlui/handle/11441/18259
Autor:
Mariano Provencio Pulla, Ana Grueso López, Luis de la Cruz-Merino, Fernando Henao Carrasco, Tomás Álvaro, Cristina Callau, Esteban Nogales Fernández, Ana Illescas Vacas, Marylène Lejeune
Publikováno v:
Clinical and Developmental Immunology
Clinical and Developmental Immunology, Vol 2012 (2012)
Clinical and Developmental Immunology, Vol 2012 (2012)
Hodgkin's lymphoma represents one of the most frequent lymphoproliferative syndromes, especially in young population. Although HL is considered one of the most curable tumors, a sizeable fraction of patients recur after successful upfront treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4bc83c140115f44a0788714dec8165f
http://europepmc.org/articles/PMC3426211
http://europepmc.org/articles/PMC3426211
Autor:
M. Provencio Pulla, Oscar Juan, Vicent Giner-Bosch, Ana Grueso López, J. Gasent Blesa, V. Giner Marco, E. Grande Pulido, V. Alberola Candel
Publikováno v:
Journal of Clinical Oncology. 27:e20647-e20647
e20647 Background: The aim of this retrospective study, is to measure the influence of the tumor control with chemo on the results of the chemo-induced anemia treatment with epos in pts with nsclc, that were non-anemic before chemo, and in whom the o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::160b8c362bff55cdecfdbdfee4b46a48
https://doi.org/10.1200/jco.2009.27.15_suppl.e20647
https://doi.org/10.1200/jco.2009.27.15_suppl.e20647